Page last updated: 2024-10-22

aprindine and Basal Ganglia Diseases

aprindine has been researched along with Basal Ganglia Diseases in 2 studies

Aprindine: A class Ib anti-arrhythmia agent used to manage ventricular and supraventricular arrhythmias.

Basal Ganglia Diseases: Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Freyland, MD1
Steffel, D1
Hilger, HH1
Gerlach, D1
Lüllmann, H1
Schaefer, J1

Other Studies

2 other studies available for aprindine and Basal Ganglia Diseases

ArticleYear
[Clinical observations of the new anti-arrhythmic drug aprindine from long-term trend analyses(author's transl)].
    Deutsche medizinische Wochenschrift (1946), 1975, Sep-05, Volume: 100, Issue:36

    Topics: Adolescent; Adult; Aged; Aprindine; Basal Ganglia Diseases; Cardiac Complexes, Premature; Electrocar

1975
[Special problems of antiarrhythmic therapy as shown on the example of a tachycardia with atrioventricular dissociation].
    Deutsche medizinische Wochenschrift (1946), 1975, Sep-05, Volume: 100, Issue:36

    Topics: Adolescent; Aprindine; Basal Ganglia Diseases; Blood Pressure; Female; Glucocorticoids; Humans; Tach

1975